• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Coma

Coma - 569 Studies Found

Terminated : Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
: Sarcoma
: 2000-11-06
: Drug: topotecan hydrochloride
Completed : Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
: Sarcoma
: 2005-06-02
:
  • Drug: carboplatin
  • Drug: paclitaxel

Completed : Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
: Sarcoma
: 1999-11-01
:
  • Biological: filgrastim
  • Drug: ifosfamide

Completed : Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
: Sarcoma
: 1999-11-01
:
  • Drug: cisplatin
  • Drug: ifosfamide

Completed : Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
:
  • Advanced Ovarian Carcinoma
  • Primary Peritoneal Carcinoma
  • Ov
    : 2007-08-03
    : Drug: Avastin Initial Treatment:
Completed : Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
:
  • Fallopian Tube Carcinoma
  • Infectious Disorder
  • Neutropenia : 2006-07-13
    :
    • Procedure: Adjuvant Therapy
    • Drug: Carbopla

Active, not recruiting : Proton Beam Therapy for Chondrosarcoma
: Chondrosarcoma
: 2007-07-02
: Procedure: Proton Beam Therapy A total dose of up to 70 CGE given at 2.0 CGE per daily fraction for 35 f
Completed : Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull Base
: Chondrosarcoma
: 2010-08-12
:
  • Radiation: carbon ion therapy

Active, not recruiting : Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
:
  • Chondrosarcoma
  • Metastatic Chondrosarcoma<
    : 2011-04-06
    : Drug: pazopanib Pazopanib 800 mg orally once daily will be started on Cycle 1 Day 1 and will be administ
Suspended : A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas
: Chondrosarcoma
: 2013-12-06
:
  • Drug: Everolimus 2.5 mg/day Co

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.